N-(PYRIDIN-2-YLSULFONYL)CYCLOPROPANECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF A CFTR MEDIATED DISEASE
申请人:Novartis AG
公开号:EP3897832A1
公开(公告)日:2021-10-27
[EN] N-(PYRIDIN-2-YLSULFONYL)CYCLOPROPANECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF A CFTR MEDIATED DISEASE<br/>[FR] DÉRIVÉS N-(PYRIDIN-2-YLSULFONYL)CYCLOPROPANECARBOXAMIDE ET LEUR UTILISATION DANS LE TRAITEMENT D'UNE MALADIE MÉDIÉE PAR CFTR
申请人:NOVARTIS AG
公开号:WO2020128768A1
公开(公告)日:2020-06-25
The invention relates to heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.